Error loading player: No playable sources found
NWFT08
The Current State of the 340B Program
Date
January 19, 2023
Explore related products in the following collection:
The 340B Drug Pricing Program is administered by the Office of Pharmacy Affairs (OPA) and requires drug manufacturers to provide front-end discounts on covered outpatient drugs purchased by covered entities. During this session we will provide an overall introduction to the 340B program and discuss key compliance and self-audit considerations. We will also address the management of contract pharmacy arrangements, 340B program administrators, and Health Center strategies related to manufacturer restrictions.
Speaker
Catherine Gilpin, CPA
Managing Director, FORVIS
Related Products
Grants Management and FFR
In addition to step by step instruction on how to fill out and file the Federal Financial Report (FFR Form 425), this session also provides an outline that includes an understanding of its purpose and guidance on the information collected on the FFR form…
Budgeting and Profitability
Health centers need to have positive bottom lines to fund growth and development. This session will show the link between budgeting and profitability and identify key drivers of the health center’s bottom line…
Grants Management and FFR (cont.)
In addition to step by step instruction on how to fill out and file the Federal Financial Report (FFR Form 425), this session also provides an outline that includes an understanding of its purpose and guidance on the information collected on the FFR form…
CHC preparing for 2025
This session will address the current trends of health care and the issues that the CHC of 2025 may face…
